ALHC
Alignment Healthcare, Inc.
- Latest sale
- $202k
- Sep 17 · No plan
- Form 4 sales
- 300
- On record
- Form 144 notices
- 22
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleRoutineJul 10 2026
Sold 298,000 shares at $19.86 ($5.9M)
Kao John E, Chief Executive Officer
10b5-1 planSold 21.5% of holdings ($27.5M position)1.1M shares left2.1x usual sizeFiling
- 2 Form 4 saleUnusualJul 15 +5 days
Sold 177,068 shares at $20.83 ($3.7M)
Maroney Dawn Christine, President
10b5-1 planSold 16.1% of holdings ($22.9M position)922,313 shares left5.9x usual sizeFiling
- 3 Form 4 saleRoutineAug 10 +26 days
Sold 298,000 shares at $13.88 ($4.1M)
Kao John E, Chief Executive Officer
10b5-1 planSold 27.4% of holdings ($15.1M position)790,766 shares left1.8x usual sizeFiling
- 4 Form 4 saleRoutineAug 14 +4 days
Sold 5,000 shares at $14.00 ($70k)
Maroney Dawn Christine, President
10b5-1 planSold 0.5% of holdings ($12.9M position)917,313 shares left0.2x usual sizeFiling
- 5 Form 4 saleUnusualSep 11 +28 days
Sold 557,870 shares at $12.77 ($7.1M)
Kao John E, Chief Executive Officer
10b5-1 planSold 47.4% of holdings ($15M position)618,166 shares left3.1x usual sizeFiling
- 6 Form 4 saleUnusualSep 11 same day
Sold 122,707 shares at $12.68 ($1.6M)
Maroney Dawn Christine, President
No 10b5-1 planSold 13.4% of holdings ($11.6M position)794,606 shares left4.1x usual sizeFiling
- 7 Form 4 saleRoutineSep 14 +3 days
Sold 27,400 shares at $13.00 ($356k)
Kao John E, Chief Executive Officer
10b5-1 planSold 4.4% of holdings ($8M position)590,766 shares left0.2x usual sizeFiling
- 8 Form 4 saleNo planSep 17 +3 days
Sold 23,511 shares at $8.61 ($202k)
Konowiecki Joseph S, EVP, Corporate Affairs
No 10b5-1 planSold 2.1% of holdings ($9.5M position)1.1M shares left0.9x usual sizeFiling
Every transaction
Loading transactions…
Sales, notices and lockups (322)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | Konowiecki Joseph S | EVP, Corporate Affairs | Form 4 sale | 23,511 | $202k | 2.1% | No plan | SEC |
| Sep 14, 2026 | Kao John E | Chief Executive Officer | Form 4 sale | 27,400 | $356k | 4.4% | Routine | SEC |
| Sep 11, 2026 | Maroney Dawn Christine | President | Form 4 sale | 122,707 | $1.6M | 13.4% | Unusual | SEC |
| Sep 11, 2026 | Kao John E | Chief Executive Officer | Form 4 sale | 557,870 | $7.1M | 47.4% | Unusual | SEC |
| Aug 14, 2026 | Maroney Dawn Christine | President | Form 4 sale | 5,000 | $70k | 0.5% | Routine | SEC |
| Aug 10, 2026 | Kao John E | Chief Executive Officer | Form 4 sale | 298,000 | $4.1M | 27.4% | Routine | SEC |
| Jul 15, 2026 | Maroney Dawn Christine | President | Form 4 sale | 177,068 | $3.7M | 16.1% | Unusual | SEC |
| Jul 10, 2026 | Kao John E | Chief Executive Officer | Form 4 sale | 298,000 | $5.9M | 21.5% | Routine | SEC |
| Jul 1, 2026 | Konowiecki Joseph S | EVP, Corporate Affairs | Form 4 sale | 25,000 | $600k | 2.2% | Routine | SEC |
| Jun 26, 2026 | Konowiecki Joseph S | EVP, Corporate Affairs | Form 4 sale | 25,000 | $575k | 2.2% | Routine | SEC |
| Jun 18, 2026 | Konowiecki Joseph S | EVP, Corporate Affairs | Form 4 sale | 25,000 | $550k | 2.1% | Routine | SEC |
| Jun 15, 2026 | Maroney Dawn Christine | President | Form 4 sale | 30,000 | $587k | 3.1% | Routine | SEC |
| Jun 12, 2026 | Kim Hyong | Chief Medical Officer | Form 4 sale | 35,951 | $714k | 9.8% | Routine | SEC |
| Jun 11, 2026 | Konowiecki Joseph S | EVP, Corporate Affairs | Form 4 sale | 25,000 | $525k | 2.1% | Routine | SEC |
| Jun 10, 2026 | Kao John E | Chief Executive Officer | Form 4 sale | 298,000 | $6.1M | 17.7% | Routine | SEC |
| May 15, 2026 | Maroney Dawn Christine | President | Form 4 sale | 30,000 | $483k | 2.9% | Routine | SEC |
| May 11, 2026 | Kao John E | Chief Executive Officer | Form 4 sale | 298,000 | $5M | 16.5% | Routine | SEC |
| Apr 15, 2026 | Maroney Dawn Christine | President | Form 4 sale | 30,000 | $626k | 2.8% | Routine | SEC |
| Apr 13, 2026 | Kao John E | Chief Executive Officer | Form 4 sale | 298,000 | $6.2M | 14.2% | Routine | SEC |
| Apr 7, 2026 | Head James M | Chief Financial Officer | Form 4 sale | 11,100 | $234k | 6.0% | No plan | SEC |
| Apr 7, 2026 | Kao John E | Chief Executive Officer | Form 4 sale | 250,000 | $5.3M | 10.6% | Routine | SEC |
| Apr 1, 2026 | Joyce Christopher J | Chief Legal and Admin. Officer | Form 4 sale | 18,013 | $320k | 5.6% | Routine | SEC |
| Mar 23, 2026 | Kao John E | Chief Executive Officer | Form 4 sale | 118,000 | $2.1M | 4.8% | Routine | SEC |
| Mar 19, 2026 | Wagner Andreas P. | Chief Human Resources Officer | Form 4 sale | 23,602 | $425k | 13.7% | Routine | SEC |
| Mar 18, 2026 | Burzacchi Sebastian | COO - Mgmt Services Org | Form 4 sale | 15,361 | $274k | 5.6% | No plan | SEC |
| Mar 18, 2026 | Kim Hyong | Chief Medical Officer | Form 4 sale | 18,404 | $328k | 4.8% | No plan | SEC |
| Mar 18, 2026 | Joyce Christopher J | Chief Legal and Admin. Officer | Form 4 sale | 25,125 | $448k | 7.2% | No plan | SEC |
| Mar 18, 2026 | Maroney Dawn Christine | President | Form 4 sale | 36,749 | $656k | 3.4% | No plan | SEC |
| Mar 18, 2026 | Kao John E | Chief Executive Officer | Form 4 sale | 73,046 | $1.3M | 3.9% | No plan | SEC |
| Mar 18, 2026 | Scavo Robert L. | Chief Information Officer | Form 4 sale | 11,285 | $201k | 2.3% | No plan | SEC |
| Mar 16, 2026 | Maroney Dawn Christine | President | Form 4 sale | 30,000 | $524k | 2.7% | Routine | SEC |
| Mar 12, 2026 | Scavo Robert L. | Chief Information Officer | Form 4 sale | 4,044 | $71k | 0.8% | No plan | SEC |
| Mar 12, 2026 | Maroney Dawn Christine | President | Form 4 sale | 29,113 | $508k | 2.9% | No plan | SEC |
| Mar 12, 2026 | Kao John E | Chief Executive Officer | Form 4 sale | 48,899 | $853k | 3.1% | No plan | SEC |
| Mar 10, 2026 | Kao John E | Chief Executive Officer | Form 4 sale | 180,000 | $3.3M | 6.8% | Routine | SEC |
| Mar 4, 2026 | Wagner Andreas P. | Chief Human Resources Officer | Form 4 sale | 21,118 | $393k | 12.4% | Routine | SEC |
| Feb 17, 2026 | Maroney Dawn Christine | President | Form 4 sale | 30,000 | $619k | 2.9% | Routine | SEC |
| Feb 10, 2026 | Wagner Andreas P. | Chief Human Resources Officer | Form 4 sale | 22,238 | $455k | 11.6% | No plan | SEC |
| Feb 10, 2026 | Kao John E | Chief Executive Officer | Form 4 sale | 180,000 | $3.7M | 6.4% | Routine | SEC |
| Jan 15, 2026 | Maroney Dawn Christine | President | Form 4 sale | 30,000 | $674k | 2.8% | Routine | SEC |
| Jan 12, 2026 | Kao John E | Chief Executive Officer | Form 4 sale | 180,000 | $3.8M | 6.0% | Routine | SEC |
| Jan 6, 2026 | Kim Hyong | Chief Medical Officer | Form 4 sale | 16,506 | $352k | 4.7% | Routine | SEC |
| Jan 6, 2026 | Maroney Dawn Christine | President | Form 4 sale | 328,152 | $6.9M | 23.7% | Unusual | SEC |
| Jan 2, 2026 | Joyce Christopher J | Chief Legal and Admin. Officer | Form 4 sale | 10,611 | $213k | 3.4% | Routine | SEC |
| Dec 29, 2025 | Scavo Robert L. | Chief Information Officer | Form 4 sale | 69,541 | $1.3M | 12.1% | Unusual | SEC |
| Dec 29, 2025 | Kim Hyong | Chief Medical Officer | Form 4 sale | 12,694 | $238k | 3.5% | No plan | SEC |
| Dec 29, 2025 | Kao John E | Chief Executive Officer | Form 4 sale | 605,648 | $11.4M | 21.3% | Unusual | SEC |
| Dec 29, 2025 | Maroney Dawn Christine | President | Form 4 sale | 282,070 | $5.3M | 16.9% | Unusual | SEC |
| Dec 29, 2025 | Joyce Christopher J | Chief Legal and Admin. Officer | Form 4 sale | 16,187 | $303k | 5.0% | No plan | SEC |
| Dec 15, 2025 | Maroney Dawn Christine | President | Form 4 sale | 130,000 | $2.6M | 7.2% | Unusual | SEC |
| Dec 12, 2025 | General Atlantic (ALN HLTH), L.P. | 10% owner | Form 4 sale | 11.1M | $206M | 45.2% | Unusual | SEC |
| Dec 12, 2025 | General Atlantic Genpar, L.P. | 10% owner | Form 4 sale | 11.1M | $206M | 45.2% | Unusual | SEC |
| Dec 10, 2025 | Burzacchi Sebastian | COO - Mgmt Services Org | Form 4 sale | 12,585 | $242k | 5.0% | No plan | SEC |
| Dec 10, 2025 | Kao John E | Chief Executive Officer | Form 4 sale | 180,000 | $3.4M | 7.1% | Routine | SEC |
| Dec 8, 2025 | Joyce Christopher J | Chief Legal and Admin. Officer | Form 4 sale | 19,706 | $381k | 5.7% | Routine | SEC |
| Nov 25, 2025 | Konowiecki Joseph S | Director | Form 4 sale | 25,000 | $475k | 2.3% | Routine | SEC |
| Nov 11, 2025 | Konowiecki Joseph S | Director | Form 4 sale | 4,832 | $80k | 0.4% | No plan | SEC |
| Nov 10, 2025 | Kao John E | Chief Executive Officer | Form 4 sale | 180,000 | $2.9M | 6.7% | Routine | SEC |
| Oct 28, 2025 | Konowiecki Joseph S | Director | Form 4 sale | 25,000 | $450k | 2.3% | Routine | SEC |
| Oct 10, 2025 | Kao John E | Chief Executive Officer | Form 4 sale | 180,000 | $3.1M | 6.2% | Routine | SEC |
| Oct 9, 2025 | Kim Hyong | Chief Medical Officer | Form 4 sale | 85,034 | $1.5M | 19.0% | Unusual | SEC |
| Sep 17, 2025 | General Atlantic (ALN HLTH), L.P. | Director, 10% owner | Form 4 sale | 6.2M | $100M | 20.3% | No plan | SEC |
| Sep 17, 2025 | General Atlantic Partners 95, L.P. | Director, 10% owner | Form 4 sale | 6.2M | $100M | 20.3% | No plan | SEC |
| Sep 16, 2025 | Konowiecki Joseph S | Director | Form 4 sale | 16,076 | $261k | 1.4% | No plan | SEC |
| Sep 12, 2025 | General Atlantic (ALN HLTH), L.P. | Director, 10% owner | Form 4 sale | 13.5M | $215M | 30.4% | Unusual | SEC |
| Sep 12, 2025 | GAP Coinvestments CDA, L.P. | Director, 10% owner | Form 4 sale | 13.5M | $215M | 30.4% | Unusual | SEC |
| Sep 10, 2025 | Scavo Robert L. | Chief Information Officer | Form 4 sale | 29,535 | $485k | 4.9% | Unusual | SEC |
| Sep 10, 2025 | Maroney Dawn Christine | President | Form 4 sale | 215,662 | $3.5M | 10.7% | Unusual | SEC |
| Sep 10, 2025 | Kao John E | Chief Executive Officer | Form 4 sale | 535,018 | $8.8M | 10.6% | Unusual | SEC |
| Sep 10, 2025 | Joyce Christopher J | Chief Legal and Admin. Officer | Form 4 sale | 30,939 | $508k | 8.3% | No plan | SEC |
| Sep 9, 2025 | Konowiecki Joseph S | Director | Form 4 sale | 25,000 | $425k | 2.2% | Routine | SEC |
| Aug 25, 2025 | Wagner Andreas P. | Chief Human Resources Officer | Form 4 sale | 12,032 | $198k | 5.9% | Routine | SEC |
| Aug 22, 2025 | Kim Hyong | Chief Medical Officer | Form 4 sale | 24,800 | $397k | 5.3% | Routine | SEC |
| Aug 13, 2025 | Kim Hyong | Chief Medical Officer | Form 4 sale | 18,600 | $280k | 3.8% | Routine | SEC |
| Aug 13, 2025 | Maroney Dawn Christine | President | Form 4 sale | 30,000 | $447k | 1.5% | Routine | SEC |
| Aug 11, 2025 | Kim Hyong | Chief Medical Officer | Form 4 sale | 18,600 | $270k | 3.7% | Routine | SEC |
| Aug 11, 2025 | Kao John E | Chief Executive Officer | Form 4 sale | 180,000 | $2.6M | 11.6% | Routine | SEC |
| Jul 31, 2025 | Joyce Christopher J | Chief Legal and Admin. Officer | Form 4 sale | 15,491 | $248k | 4.0% | Routine | SEC |
| Jul 31, 2025 | Konowiecki Joseph S | Director | Form 4 sale | 25,000 | $400k | 2.1% | Routine | SEC |
| Jul 14, 2025 | Maroney Dawn Christine | President | Form 4 sale | 30,000 | $403k | 1.4% | Routine | SEC |
| Jul 10, 2025 | Kao John E | Chief Executive Officer | Form 4 sale | 180,000 | $2.4M | 10.4% | Routine | SEC |
| Jun 16, 2025 | Kao John E | Chief Executive Officer | Form 4 sale | 90,000 | $1.3M | 4.9% | Routine | SEC |
| Jun 16, 2025 | Maroney Dawn Christine | President | Form 4 sale | 30,000 | $434k | 1.4% | Routine | SEC |
| Jun 11, 2025 | Wagner Andreas P. | Chief Human Resources Officer | Form 4 sale | 19,399 | $296k | 8.7% | Routine | SEC |
| Jun 11, 2025 | Scavo Robert L. | Chief Information Officer | Form 4 sale | 100,863 | $1.5M | 14.3% | Unusual | SEC |
| Jun 11, 2025 | Kao John E | Chief Executive Officer | Form 4 sale | 90,000 | $1.4M | 4.7% | Routine | SEC |
| May 19, 2025 | General Atlantic (ALN HLTH), L.P. | Director, 10% owner | Form 4 sale | 17M | $260M | 27.7% | Unusual | SEC |
| May 19, 2025 | General Atlantic Partners 95, L.P. | Director, 10% owner | Form 4 sale | 17M | $260M | 27.7% | Unusual | SEC |
| May 14, 2025 | Maroney Dawn Christine | President | Form 4 sale | 30,000 | $446k | 1.4% | Routine | SEC |
| May 12, 2025 | Kao John E | Chief Executive Officer | Form 4 sale | 90,000 | $1.3M | 4.5% | Routine | SEC |
| May 1, 2025 | Joyce Christopher J | Chief Legal and Admin. Officer | Form 4 sale | 25,000 | $422k | 6.0% | Routine | SEC |
| Apr 14, 2025 | Maroney Dawn Christine | President | Form 4 sale | 230,000 | $4.4M | 9.7% | Unusual | SEC |
| Apr 14, 2025 | Kao John E | Chief Executive Officer | Form 4 sale | 90,000 | $1.7M | 4.3% | Routine | SEC |
| Apr 1, 2025 | Joyce Christopher J | Chief Legal and Admin. Officer | Form 4 sale | 25,000 | $462k | 5.7% | Routine | SEC |
| Mar 27, 2025 | Scavo Robert L. | Chief Information Officer | Form 4 sale | 2,864 | $51k | 0.4% | No plan | SEC |
| Mar 27, 2025 | Kardes Hakan | Chief Experience Officer | Form 4 sale | 7,225 | $129k | 1.1% | No plan | SEC |
| Mar 27, 2025 | Maroney Dawn Christine | President | Form 4 sale | 11,152 | $200k | 0.5% | No plan | SEC |
| Mar 27, 2025 | Freeman Robert Thomas | Chief Financial Officer | Form 4 sale | 6,744 | $121k | 0.5% | No plan | SEC |
| Mar 27, 2025 | Kao John E | Chief Executive Officer | Form 4 sale | 34,430 | $616k | 0.7% | No plan | SEC |
| Mar 20, 2025 | Kim Hyong | Chief Medical Officer | Form 4 sale | 26,734 | $460k | 5.0% | Routine | SEC |
| Mar 19, 2025 | Wagner Andreas P. | Chief Human Resources Officer | Form 4 sale | 12,520 | $208k | 5.3% | No plan | SEC |
| Mar 19, 2025 | Burzacchi Sebastian | COO - Mgmt Services Org | Form 4 sale | 6,694 | $110k | 2.6% | No plan | SEC |
| Mar 19, 2025 | Scavo Robert L. | Chief Information Officer | Form 4 sale | 11,157 | $185k | 1.6% | No plan | SEC |
| Mar 19, 2025 | Kardes Hakan | Chief Experience Officer | Form 4 sale | 31,602 | $534k | 4.4% | Routine | SEC |
| Mar 19, 2025 | Joyce Christopher J | Chief Legal and Admin. Officer | Form 4 sale | 17,741 | $294k | 3.9% | No plan | SEC |
| Mar 19, 2025 | Kim Hyong | Chief Medical Officer | Form 4 sale | 8,266 | $136k | 1.5% | No plan | SEC |
| Mar 19, 2025 | Maroney Dawn Christine | President | Form 4 sale | 43,649 | $729k | 1.8% | No plan | SEC |
| Mar 19, 2025 | Freeman Robert Thomas | Chief Financial Officer | Form 4 sale | 25,247 | $421k | 1.7% | No plan | SEC |
| Mar 19, 2025 | Kao John E | Chief Executive Officer | Form 4 sale | 61,636 | $1M | 1.2% | No plan | SEC |
| Mar 17, 2025 | Maroney Dawn Christine | President | Form 4 sale | 30,000 | $480k | 1.2% | Routine | SEC |
| Mar 12, 2025 | Scavo Robert L. | Chief Information Officer | Form 4 sale | 5,313 | $82k | 0.8% | No plan | SEC |
| Mar 12, 2025 | Kardes Hakan | Chief Experience Officer | Form 4 sale | 4,856 | $75k | 0.7% | No plan | SEC |
| Mar 12, 2025 | Maroney Dawn Christine | President | Form 4 sale | 27,243 | $420k | 1.2% | No plan | SEC |
| Mar 12, 2025 | Freeman Robert Thomas | Chief Financial Officer | Form 4 sale | 14,692 | $227k | 1.0% | No plan | SEC |
| Mar 12, 2025 | Kao John E | Chief Executive Officer | Form 4 sale | 143,122 | $2.2M | 6.4% | Routine | SEC |
| Mar 7, 2025 | Kim Hyong | Chief Medical Officer | Form 4 sale | 21,574 | $325k | 4.2% | Routine | SEC |
| Mar 6, 2025 | Scavo Robert L. | Chief Information Officer | Form 4 sale | 55,403 | $860k | 7.6% | Unusual | SEC |
| Mar 6, 2025 | Maroney Dawn Christine | President | Form 4 sale | 278,917 | $4.3M | 10.8% | Unusual | SEC |
| Mar 6, 2025 | Kim Hyong | Chief Medical Officer | Form 4 sale | 21,020 | $329k | 4.0% | No plan | SEC |
| Mar 6, 2025 | Freeman Robert Thomas | Chief Financial Officer | Form 4 sale | 468,295 | $7.3M | 24.8% | Unusual | SEC |
| Mar 6, 2025 | Kao John E | Chief Executive Officer | Form 4 sale | 554,713 | $8.6M | 10.5% | Unusual | SEC |
| Mar 6, 2025 | Joyce Christopher J | Chief Legal and Admin. Officer | Form 4 sale | 35,871 | $558k | 8.5% | Routine | SEC |
| Mar 6, 2025 | Kardes Hakan | Chief Experience Officer | Form 4 sale | 86,659 | $1.3M | 11.3% | Unusual | SEC |
| Feb 18, 2025 | Maroney Dawn Christine | President | Form 4 sale | 30,000 | $412k | 1.9% | Routine | SEC |
| Feb 12, 2025 | Wagner Andreas P. | Chief Human Resources Officer | Form 4 sale | 14,878 | $214k | 6.9% | No plan | SEC |
| Feb 11, 2025 | Kao John E | Chief Executive Officer | Form 4 sale | 90,000 | $1.3M | 4.0% | Routine | SEC |
| Jan 24, 2025 | Kardes Hakan | Chief Experience Officer | Form 4 sale | 14,500 | $217k | 4.7% | Routine | SEC |
| Jan 21, 2025 | Kardes Hakan | Chief Experience Officer | Form 4 sale | 10,500 | $157k | 3.3% | Routine | SEC |
| Jan 15, 2025 | Maroney Dawn Christine | President | Form 4 sale | 30,000 | $408k | 1.8% | Routine | SEC |
| Jan 13, 2025 | Kao John E | Chief Executive Officer | Form 4 sale | 90,000 | $1.2M | 3.8% | Routine | SEC |
| Dec 16, 2024 | Maroney Dawn Christine | President, Markets | Form 4 sale | 30,000 | $340k | 1.8% | Routine | SEC |
| Dec 16, 2024 | Maroney Dawn Christine | Officer | Form 144 notice | 90,000 | $1M | Notice | SEC | |
| Dec 11, 2024 | Kao John E | Chief Executive Officer | Form 4 sale | 90,000 | $1M | 3.7% | Routine | SEC |
| Dec 10, 2024 | Burzacchi Sebastian | COO - Mgmt Services Org | Form 4 sale | 8,550 | $96k | 3.8% | No plan | SEC |
| Dec 10, 2024 | Burzacchi Sebastian | Officer | Form 144 notice | 8,550 | $96k | Notice | SEC | |
| Dec 5, 2024 | Kim Hyong | Chief Medical Officer | Form 4 sale | 62,574 | $764k | 11.7% | Routine | SEC |
| Dec 5, 2024 | Kim Hyong | Officer | Form 144 notice | 62,574 | $783k | Notice | SEC | |
| Nov 27, 2024 | Kardes Hakan | Chief Experience Officer | Form 4 sale | 35,000 | $448k | 9.8% | No plan | SEC |
| Nov 27, 2024 | Kardes Hakan | Officer | Form 144 notice | 35,000 | $448k | Notice | SEC | |
| Nov 15, 2024 | Maroney Dawn Christine | President, Markets | Form 4 sale | 30,000 | $341k | 1.7% | Routine | SEC |
| Nov 11, 2024 | Konowiecki Joseph S | Director | Form 4 sale | 6,920 | $95k | 0.6% | No plan | SEC |
| Nov 11, 2024 | Freeman Robert Thomas | Chief Financial Officer | Form 4 sale | 30,500 | $409k | 24.7% | Routine | SEC |
| Nov 11, 2024 | Kao John E | Chief Executive Officer | Form 4 sale | 90,000 | $1.2M | 3.5% | Routine | SEC |
| Nov 4, 2024 | Kardes Hakan | Chief Experience Officer | Form 4 sale | 25,000 | $326k | 6.6% | Routine | SEC |
| Oct 31, 2024 | Freeman Robert Thomas | Chief Financial Officer | Form 4 sale | 40,680 | $490k | 24.8% | Routine | SEC |
| Oct 15, 2024 | Maroney Dawn Christine | President, Markets | Form 4 sale | 30,000 | $323k | 1.7% | Routine | SEC |
| Oct 14, 2024 | Freeman Robert Thomas | Chief Financial Officer | Form 4 sale | 30,500 | $351k | 15.7% | Routine | SEC |
| Oct 9, 2024 | Kao John E | Chief Executive Officer | Form 4 sale | 90,000 | $1M | 3.4% | Unusual | SEC |
| Oct 8, 2024 | Kim Hyong | Chief Medical Officer | Form 4 sale | 22,460 | $248k | 4.0% | No plan | SEC |
| Oct 8, 2024 | Freeman Robert Thomas | Chief Financial Officer | Form 4 sale | 39,320 | $473k | 16.8% | Routine | SEC |
| Oct 2, 2024 | Freeman Robert Thomas | Chief Financial Officer | Form 4 sale | 30,500 | $328k | 11.5% | Routine | SEC |
| Oct 1, 2024 | Joyce Christopher J | Chief Legal and Admin. Officer | Form 4 sale | 667 | $8k | 0.2% | Routine | SEC |
| Sep 17, 2024 | Konowiecki Joseph S | Director | Form 4 sale | 16,413 | $193k | 1.4% | No plan | SEC |
| Sep 16, 2024 | Maroney Dawn Christine | President, Markets | Form 4 sale | 30,000 | $351k | 1.7% | Routine | SEC |
| Sep 16, 2024 | Kao John E | Chief Executive Officer | Form 4 sale | 90,000 | $1.1M | 3.3% | Unusual | SEC |
| Sep 13, 2024 | Konowiecki Joseph S | Director | Form 4 sale | 50,000 | $575k | 4.1% | Routine | SEC |
| Sep 13, 2024 | Freeman Robert Thomas | Chief Financial Officer | Form 4 sale | 143,561 | $1.6M | 35.2% | Unusual | SEC |
| Sep 12, 2024 | Kardes Hakan | Chief Experience Officer | Form 4 sale | 25,000 | $287k | 6.2% | Routine | SEC |
| Sep 11, 2024 | Joyce Christopher J | Chief Legal and Admin. Officer | Form 4 sale | 34,626 | $333k | 8.7% | Routine | SEC |
| Sep 5, 2024 | Joyce Christopher J | Chief Legal and Admin. Officer | Form 4 sale | 5,841 | $58k | 1.4% | Routine | SEC |
| Sep 5, 2024 | Freeman Robert Thomas | Chief Financial Officer | Form 4 sale | 6,439 | $64k | 1.6% | Routine | SEC |
| Aug 23, 2024 | Maroney Dawn Christine | President, Markets | Form 4 sale | 10,000 | $90k | 0.6% | Routine | SEC |
| Aug 15, 2024 | Maroney Dawn Christine | President, Markets | Form 4 sale | 20,000 | $174k | 1.1% | Routine | SEC |
| Aug 14, 2024 | Margolis Jeffrey H | Director | Form 4 sale | 1,200 | $11k | 0.3% | Routine | SEC |
| Aug 2, 2024 | Joyce Christopher J | Chief Legal and Admin. Officer | Form 4 sale | 1,333 | $12k | 0.3% | Routine | SEC |
| Jul 19, 2024 | Maroney Dawn Christine | President, Markets | Form 4 sale | 100,000 | $1M | 5.2% | Unusual | SEC |
| Jul 19, 2024 | Freeman Robert Thomas | Chief Financial Officer | Form 4 sale | 105,000 | $1.1M | 20.2% | Unusual | SEC |
| Jul 17, 2024 | Konowiecki Joseph S | Director | Form 4 sale | 25,000 | $250k | 2.0% | Routine | SEC |
| Jul 16, 2024 | Kardes Hakan | Chief Experience Officer | Form 4 sale | 25,000 | $250k | 5.8% | Unusual | SEC |
| Jul 15, 2024 | Konowiecki Joseph S | Chairman of the Board | Form 4 sale | 25,000 | $226k | 2.0% | Routine | SEC |
| Jul 15, 2024 | Margolis Jeffrey H | Director | Form 4 sale | 1,200 | $11k | 0.3% | Routine | SEC |
| Jul 15, 2024 | Joyce Christopher J | Chief Legal and Admin. Officer | Form 4 sale | 15,334 | $139k | 3.6% | Routine | SEC |
| Jul 15, 2024 | Maroney Dawn Christine | President, Markets | Form 4 sale | 40,000 | $362k | 2.0% | Routine | SEC |
| Jul 1, 2024 | Joyce Christopher J | Chief Legal and Admin. Officer | Form 4 sale | 666 | $5k | 0.2% | Routine | SEC |
| Jun 14, 2024 | Joyce Christopher J | Chief Legal and Admin. Officer | Form 4 sale | 16,000 | $128k | 3.6% | Routine | SEC |
| Jun 14, 2024 | Margolis Jeffrey H | Director | Form 4 sale | 1,200 | $10k | 0.3% | Routine | SEC |
| Jun 12, 2024 | Maroney Dawn Christine | President, Markets | Form 4 sale | 20,000 | $164k | 1.0% | Routine | SEC |
| Mar 28, 2024 | Scavo Robert L. | Chief Information Officer | Form 4 sale | 1,821 | $9k | 0.4% | No plan | SEC |
| Mar 28, 2024 | Maroney Dawn Christine | President, Markets | Form 4 sale | 10,151 | $49k | 0.5% | No plan | SEC |
| Mar 28, 2024 | Freeman Robert Thomas | Chief Financial Officer | Form 4 sale | 4,299 | $21k | 0.5% | No plan | SEC |
| Mar 28, 2024 | Kardes Hakan | Chief Experience Officer | Form 4 sale | 4,363 | $21k | 1.0% | No plan | SEC |
| Mar 20, 2024 | Maroney Dawn Christine | President, Markets | Form 4 sale | 29,113 | $144k | 1.4% | No plan | SEC |
| Mar 19, 2024 | Scavo Robert L. | Chief Information Officer | Form 4 sale | 3,078 | $16k | 0.7% | No plan | SEC |
| Mar 19, 2024 | Joyce Christopher J | Chief Legal and Admin. Officer | Form 4 sale | 25,060 | $127k | 5.4% | No plan | SEC |
| Mar 19, 2024 | Kim Hyong | Chief Medical Officer | Form 4 sale | 5,576 | $28k | 1.0% | No plan | SEC |
| Mar 19, 2024 | Kardes Hakan | Chief Experience Officer | Form 4 sale | 18,964 | $96k | 4.2% | No plan | SEC |
| Mar 19, 2024 | Freeman Robert Thomas | Chief Financial Officer | Form 4 sale | 28,522 | $144k | 3.2% | No plan | SEC |
| Mar 15, 2024 | Scavo Robert L. | Chief Information Officer | Form 4 sale | 4,852 | $24k | 1.1% | No plan | SEC |
| Mar 15, 2024 | Maroney Dawn Christine | President, Markets | Form 4 sale | 21,537 | $105k | 1.1% | No plan | SEC |
| Mar 15, 2024 | Freeman Robert Thomas | Chief Financial Officer | Form 4 sale | 11,858 | $58k | 1.3% | No plan | SEC |
| Mar 15, 2024 | Kardes Hakan | Chief Experience Officer | Form 4 sale | 4,326 | $21k | 0.9% | No plan | SEC |
| Mar 8, 2024 | Maroney Dawn Christine | President, Markets | Form 4 sale | 23,000 | $125k | 1.2% | No plan | SEC |
| Dec 29, 2023 | Kumar Dinesh M. | Former Officer | Form 144 notice | 266 | $2k | Notice | SEC | |
| Dec 28, 2023 | Kumar Dinesh M. | Former Officer | Form 144 notice | 1,888 | $17k | Notice | SEC | |
| Dec 26, 2023 | Kumar Dinesh M. | Former Officer | Form 144 notice | 500 | $4k | Notice | SEC | |
| Dec 22, 2023 | Kumar Dinesh M. | Former Officer | Form 144 notice | 9,092 | $80k | Notice | SEC | |
| Dec 21, 2023 | Kumar Dinesh M. | Former Officer | Form 144 notice | 22,207 | $76k | Notice | SEC | |
| Dec 18, 2023 | Kumar Dinesh M. | Former Officer | Form 144 notice | 100 | $855 | Notice | SEC | |
| Dec 14, 2023 | Margolis Jeffrey H | Director | Form 4 sale | 1,200 | $10k | 0.3% | Routine | SEC |
| Dec 14, 2023 | Kumar Dinesh M. | Former Officer | Form 144 notice | 6,898 | $59k | Notice | SEC | |
| Dec 13, 2023 | Kumar Dinesh M. | Former Officer | Form 144 notice | 34,049 | $290k | Notice | SEC | |
| Dec 12, 2023 | Kumar Dinesh M. | Former Officer | Form 144 notice | 50,000 | $418k | Notice | SEC | |
| Dec 8, 2023 | Kumar Dinesh M. | Former Officer | Form 144 notice | 90,166 | $723k | Notice | SEC | |
| Dec 7, 2023 | Kumar Dinesh M. | Former Officer | Form 144 notice | 5,191 | $41k | Notice | SEC | |
| Dec 6, 2023 | Margolis Jeffrey H | Director | Form 4 sale | 1,200 | $10k | 0.3% | Routine | SEC |
| Dec 6, 2023 | Kumar Dinesh M. | Former Officer | Form 144 notice | 4,643 | $37k | Notice | SEC | |
| Dec 6, 2023 | Margolis Jeffrey H | Officer | Form 144 notice | 4,800 | $37k | Notice | SEC | |
| Nov 10, 2023 | Konowiecki Joseph S | Chairman of the Board | Form 4 sale | 4,898 | $29k | 0.4% | No plan | SEC |
| Oct 16, 2023 | Margolis Jeffrey H | Director | Form 4 sale | 6,000 | $48k | 1.4% | Routine | SEC |
| Oct 16, 2023 | Kumar Dinesh M. | Former Officer | Form 144 notice | 50,000 | $401k | Notice | SEC | |
| Oct 16, 2023 | Margolis Jeffrey H | Officer | Form 144 notice | 6,000 | $40k | Notice | SEC | |
| Sep 14, 2023 | Cross Richard A. | Affiliate | Form 144 notice | 80,000 | $432k | Notice | SEC | |
| Sep 13, 2023 | Joyce Christopher J | Chief Legal and Admin. Officer | Form 4 sale | 15,474 | $80k | 5.5% | No plan | SEC |
| Sep 13, 2023 | Joyce Christopher J | Officer | Form 144 notice | 14,196 | $80k | Notice | SEC | |
| Mar 31, 2023 | Freeman Robert Thomas | Officer | Form 144 notice | 3,290 | $21k | Notice | SEC | |
| Mar 31, 2023 | Freeman Robert Thomas | Chief Financial Officer | Form 4 sale | 8,602 | $53k | 1.2% | No plan | SEC |
| Mar 29, 2023 | Maroney Dawn Christine | President, Markets | Form 4 sale | 7,178 | $44k | 0.4% | No plan | SEC |
| Mar 29, 2023 | Kao John E | Chief Executive Officer | Form 4 sale | 34,506 | $211k | 1.4% | No plan | SEC |
| Mar 29, 2023 | Kumar Dinesh M. | Chief Med & Operating Officer | Form 4 sale | 3,286 | $20k | 0.3% | No plan | SEC |
| Mar 29, 2023 | Cross Richard A. | SVP, General Counsel | Form 4 sale | 1,710 | $10k | 0.4% | No plan | SEC |
| Mar 14, 2023 | Freeman Robert Thomas | Chief Financial Officer | Form 4 sale | 13,470 | $85k | 1.8% | Plan not stated | SEC |
| Mar 14, 2023 | Kumar Dinesh M. | Chief Med & Operating Officer | Form 4 sale | 14,164 | $90k | 1.3% | Plan not stated | SEC |
| Mar 14, 2023 | Cross Richard A. | SVP, General Counsel | Form 4 sale | 5,516 | $35k | 1.4% | Plan not stated | SEC |
| Mar 14, 2023 | Kao John E | Chief Executive Officer | Form 4 sale | 39,101 | $248k | 1.6% | Plan not stated | SEC |
| Mar 14, 2023 | Maroney Dawn Christine | President, Markets | Form 4 sale | 20,006 | $127k | 1.0% | Plan not stated | SEC |
| Feb 1, 2023 | Kumar Dinesh M. | Chief Med & Operating Officer | Form 4 sale | 10,000 | $122k | 0.9% | Plan not stated | SEC |
| Jan 18, 2023 | Kumar Dinesh M. | Chief Med & Operating Officer | Form 4 sale | 1,125 | $15k | 0.1% | Plan not stated | SEC |
| Jan 18, 2023 | Kao John E | Chief Executive Officer | Form 4 sale | 1,100 | $14k | 0.0% | Plan not stated | SEC |
| Jan 18, 2023 | Freeman Robert Thomas | Chief Financial Officer | Form 4 sale | 1,100 | $14k | 0.2% | Plan not stated | SEC |
| Jan 17, 2023 | Maroney Dawn Christine | President, Markets | Form 4 sale | 5,000 | $63k | 0.3% | Plan not stated | SEC |
| Jan 13, 2023 | Kumar Dinesh M. | Chief Med & Operating Officer | Form 4 sale | 9,000 | $109k | 0.8% | Plan not stated | SEC |
| Jan 3, 2023 | Kumar Dinesh M. | Chief Med & Operating Officer | Form 4 sale | 1,000 | $12k | 0.1% | Plan not stated | SEC |
| Dec 21, 2022 | Maroney Dawn Christine | President, Markets | Form 4 sale | 4,274 | $51k | 0.2% | Plan not stated | SEC |
| Dec 15, 2022 | Maroney Dawn Christine | President, Markets | Form 4 sale | 726 | $9k | 0.0% | Plan not stated | SEC |
| Dec 1, 2022 | Kumar Dinesh M. | Chief Med & Operating Officer | Form 4 sale | 20,000 | $262k | 1.7% | Plan not stated | SEC |
| Dec 1, 2022 | Freeman Robert Thomas | Chief Financial Officer | Form 4 sale | 24,000 | $314k | 4.4% | Plan not stated | SEC |
| Dec 1, 2022 | Kao John E | Chief Executive Officer | Form 4 sale | 25,000 | $328k | 0.9% | Plan not stated | SEC |
| Nov 1, 2022 | Kumar Dinesh M. | Chief Med & Operating Officer | Form 4 sale | 30,000 | $402k | 2.5% | Plan not stated | SEC |
| Nov 1, 2022 | Freeman Robert Thomas | Chief Financial Officer | Form 4 sale | 24,000 | $318k | 4.2% | Plan not stated | SEC |
| Nov 1, 2022 | Kao John E | Chief Executive Officer | Form 4 sale | 25,000 | $331k | 0.9% | Plan not stated | SEC |
| Oct 26, 2022 | Kumar Dinesh M. | Chief Med & Operating Officer | Form 4 sale | 10,000 | $130k | 0.8% | Plan not stated | SEC |
| Oct 26, 2022 | Freeman Robert Thomas | Chief Financial Officer | Form 4 sale | 24,000 | $314k | 4.1% | Plan not stated | SEC |
| Oct 26, 2022 | Kao John E | Chief Executive Officer | Form 4 sale | 25,000 | $327k | 0.9% | Plan not stated | SEC |
| Oct 3, 2022 | Kumar Dinesh M. | Chief Med & Operating Officer | Form 4 sale | 20,000 | $241k | 1.7% | Plan not stated | SEC |
| Sep 20, 2022 | Warburg Pincus & Co. | Director, 10% owner | Form 4 sale | 2M | $29.9M | 10.2% | Plan not stated | SEC |
| Sep 20, 2022 | Warburg Pincus XII Partners, L.P. | Director, 10% owner | Form 4 sale | 2M | $29.9M | 10.2% | Plan not stated | SEC |
| Sep 20, 2022 | General Atlantic (ALN HLTH), L.P. | Director, 10% owner | Form 4 sale | 7M | $102M | 10.2% | Plan not stated | SEC |
| Sep 20, 2022 | General Atlantic Genpar, L.P. | Director, 10% owner | Form 4 sale | 7M | $102M | 10.2% | Plan not stated | SEC |
| Sep 9, 2022 | Maroney Dawn Christine | President, Markets | Form 4 sale | 10,250 | $170k | 0.7% | Plan not stated | SEC |
| Sep 8, 2022 | Kumar Dinesh M. | Chief Med & Operating Officer | Form 4 sale | 50,000 | $803k | 5.1% | Plan not stated | SEC |
| Sep 1, 2022 | Maroney Dawn Christine | President, Markets | Form 4 sale | 20,000 | $291k | 1.3% | Plan not stated | SEC |
| Sep 1, 2022 | Kumar Dinesh M. | Chief Med & Operating Officer | Form 4 sale | 30,000 | $437k | 3.0% | Unusual | SEC |
| Sep 1, 2022 | Kao John E | Chief Executive Officer | Form 4 sale | 50,000 | $728k | 1.8% | Plan not stated | SEC |
| Sep 1, 2022 | Freeman Robert Thomas | Chief Financial Officer | Form 4 sale | 24,000 | $349k | 3.9% | Plan not stated | SEC |
| Aug 23, 2022 | Kumar Dinesh M. | Chief Med & Operating Officer | Form 4 sale | 50,000 | $800k | 4.7% | Unusual | SEC |
| Aug 23, 2022 | Maroney Dawn Christine | President, Markets | Form 4 sale | 30,000 | $477k | 1.9% | Plan not stated | SEC |
| Aug 23, 2022 | Warburg Pincus Partners GP LLC | Director, 10% owner | Form 4 sale | 682,000 | $10.6M | 3.3% | Plan not stated | SEC |
| Aug 23, 2022 | Warburg Pincus XII Partners, L.P. | Director, 10% owner | Form 4 sale | 682,000 | $10.6M | 3.3% | Plan not stated | SEC |
| Aug 15, 2022 | Maroney Dawn Christine | President, Markets | Form 4 sale | 1,790 | $30k | 0.1% | Plan not stated | SEC |
| Aug 11, 2022 | Kao John E | Chief Executive Officer | Form 4 sale | 500,000 | $8M | 14.9% | Unusual | SEC |
| Aug 9, 2022 | Warburg Pincus Partners GP LLC | Director, 10% owner | Form 4 sale | 2.1M | $34.3M | 9.3% | Plan not stated | SEC |
| Aug 9, 2022 | WP Global LLC | Director, 10% owner | Form 4 sale | 2.1M | $34.3M | 9.3% | Plan not stated | SEC |
| Aug 8, 2022 | General Atlantic (ALN HLTH), L.P. | Director, 10% owner | Form 4 sale | 2.1M | $35.8M | 3.0% | Plan not stated | SEC |
| Aug 8, 2022 | General Atlantic (SPV) GP, LLC | Director, 10% owner | Form 4 sale | 2.1M | $35.8M | 3.0% | Plan not stated | SEC |
| Aug 5, 2022 | Margolis Jeffrey H | Director | Form 4 sale | 1,200 | $22k | 0.3% | Plan not stated | SEC |
| Aug 5, 2022 | Kumar Dinesh M. | Chief Med & Operating Officer | Form 4 sale | 44,104 | $818k | 4.0% | Unusual | SEC |
| Aug 5, 2022 | Freeman Robert Thomas | Chief Financial Officer | Form 4 sale | 43,410 | $805k | 6.6% | Plan not stated | SEC |
| Aug 5, 2022 | Kao John E | Chief Executive Officer | Form 4 sale | 66,191 | $1.2M | 1.9% | Plan not stated | SEC |
| Aug 2, 2022 | Kao John E | Chief Executive Officer | Form 4 sale | 50,000 | $730k | 1.4% | Plan not stated | SEC |
| Aug 1, 2022 | Kumar Dinesh M. | Chief Med & Operating Officer | Form 4 sale | 30,000 | $435k | 2.7% | Unusual | SEC |
| Aug 1, 2022 | Maroney Dawn Christine | President, Markets | Form 4 sale | 20,000 | $289k | 1.2% | Plan not stated | SEC |
| Aug 1, 2022 | Freeman Robert Thomas | Chief Financial Officer | Form 4 sale | 24,000 | $348k | 3.5% | Plan not stated | SEC |
| Jul 11, 2022 | Kao John E | Chief Executive Officer | Form 4 sale | 4,107 | $58k | 0.1% | Plan not stated | SEC |
| Jul 8, 2022 | Maroney Dawn Christine | President, Markets | Form 4 sale | 40,000 | $567k | 2.4% | Plan not stated | SEC |
| Jul 8, 2022 | Kao John E | Chief Executive Officer | Form 4 sale | 95,893 | $1.3M | 2.7% | Plan not stated | SEC |
| Jul 6, 2022 | Kumar Dinesh M. | Chief Med & Operating Officer | Form 4 sale | 36,317 | $463k | 3.1% | Unusual | SEC |
| Jul 5, 2022 | Freeman Robert Thomas | Chief Financial Officer | Form 4 sale | 20,383 | $254k | 2.9% | Plan not stated | SEC |
| Jul 1, 2022 | Kumar Dinesh M. | Chief Med & Operating Officer | Form 4 sale | 10,000 | $114k | 0.8% | Plan not stated | SEC |
| Jul 1, 2022 | Freeman Robert Thomas | Chief Financial Officer | Form 4 sale | 12,000 | $137k | 1.7% | Plan not stated | SEC |
| Jun 22, 2022 | Kumar Dinesh M. | Chief Med & Operating Officer | Form 4 sale | 3,683 | $44k | 0.3% | Plan not stated | SEC |
| Jun 22, 2022 | Freeman Robert Thomas | Chief Financial Officer | Form 4 sale | 3,617 | $43k | 0.5% | Plan not stated | SEC |
| Jun 17, 2022 | Freeman Robert Thomas | Chief Financial Officer | Form 4 sale | 12,000 | $134k | 1.6% | Plan not stated | SEC |
| Jun 16, 2022 | Maroney Dawn Christine | President, Markets | Form 4 sale | 2,150 | $24k | 0.1% | Plan not stated | SEC |
| Jun 16, 2022 | Kumar Dinesh M. | Chief Med & Operating Officer | Form 4 sale | 10,000 | $110k | 0.8% | Plan not stated | SEC |
| Jun 2, 2022 | Maroney Dawn Christine | President, Markets | Form 4 sale | 13,782 | $153k | 0.8% | Plan not stated | SEC |
| Apr 1, 2022 | Freeman Robert Thomas | Chief Financial Officer | Form 4 sale | 8,236 | $93k | 2.0% | Plan not stated | SEC |
| Mar 31, 2022 | Shrestha Rajesh | Pres., New Markets & CBO | Form 4 sale | 14,224 | $159k | 7.7% | Plan not stated | SEC |
| Mar 31, 2022 | Maroney Dawn Christine | President, Markets | Form 4 sale | 6,681 | $75k | 0.4% | Plan not stated | SEC |
| Mar 31, 2022 | Kumar Dinesh M. | Chief Medical Officer | Form 4 sale | 3,058 | $34k | 0.3% | Plan not stated | SEC |
| Mar 31, 2022 | Kao John E | Chief Executive Officer | Form 4 sale | 26,366 | $295k | 3.3% | Plan not stated | SEC |
| Mar 31, 2022 | Furman Donald Steven | Chief Clinical Officer | Form 4 sale | 3,006 | $34k | 0.2% | Plan not stated | SEC |
| Mar 31, 2022 | Cross Richard A. | SVP, General Counsel | Form 4 sale | 1,592 | $18k | 0.5% | Plan not stated | SEC |
| Nov 23, 2021 | General Atlantic (ALN HLTH), L.P. | Director, 10% owner | Form 4 sale | 6.3M | $126M | 8.2% | Plan not stated | SEC |
| Nov 23, 2021 | GAP Coinvestments V, LLC | Director, 10% owner | Form 4 sale | 6.3M | $126M | 8.2% | Plan not stated | SEC |
| Nov 23, 2021 | Warburg Pincus Partners GP LLC | Director, 10% owner | Form 4 sale | 2M | $40.9M | 8.2% | Plan not stated | SEC |
| Nov 23, 2021 | Warburg Pincus Private Equity XII-D, L.P. | Director, 10% owner | Form 4 sale | 2M | $40.9M | 8.2% | Plan not stated | SEC |
| Nov 23, 2021 | McClellan Mark B. | Director | Form 4 sale | 7,500 | $151k | 2.6% | Plan not stated | SEC |
| Nov 23, 2021 | Maroney Dawn Christine | President, Markets | Form 4 sale | 127,843 | $2.6M | 7.8% | Plan not stated | SEC |
| Nov 23, 2021 | Kumar Dinesh M. | Chief Medical Officer | Form 4 sale | 83,367 | $1.7M | 7.8% | Plan not stated | SEC |
| Nov 23, 2021 | Kao John E | Chief Executive Officer | Form 4 sale | 419,646 | $8.4M | 10.5% | Plan not stated | SEC |
| Nov 23, 2021 | Furman Donald Steven | Chief Clinical Officer | Form 4 sale | 100,000 | $2M | 5.2% | Plan not stated | SEC |
| Nov 23, 2021 | Freeman Robert Thomas | Chief Financial Officer | Form 4 sale | 85,279 | $1.7M | 10.4% | Plan not stated | SEC |
| Nov 2, 2021 | Kao John E | Chief Executive Officer | Form 4 sale | 100,000 | $2M | 2.4% | Plan not stated | SEC |
| Nov 1, 2021 | Margolis Jeffrey H | Director | Form 4 sale | 1,200 | $24k | 0.3% | Plan not stated | SEC |
| Nov 1, 2021 | Kumar Dinesh M. | Chief Medical Officer | Form 4 sale | 10,000 | $199k | 0.9% | Plan not stated | SEC |
| Oct 20, 2021 | Freeman Robert Thomas | Chief Financial Officer | Form 4 sale | 23,000 | $446k | 2.7% | Plan not stated | SEC |
| Oct 14, 2021 | Kao John E | Chief Executive Officer | Form 4 sale | 200,000 | $3.7M | 4.7% | Plan not stated | SEC |
| Oct 13, 2021 | Margolis Jeffrey H | Director | Form 4 sale | 1,200 | $22k | 0.3% | Plan not stated | SEC |
| Oct 13, 2021 | Kumar Dinesh M. | Chief Medical Officer | Form 4 sale | 10,000 | $181k | 0.9% | Plan not stated | SEC |
| Apr 6, 2021 | Warburg Pincus & Co. | Director, 10% owner | Form 4 sale | 716,624 | $12.1M | 2.8% | Plan not stated | SEC |
| Apr 6, 2021 | Warburg Pincus Private Equity XII-B, L.P. | Director, 10% owner | Form 4 sale | 716,624 | $12.1M | 2.8% | Plan not stated | SEC |
| Apr 6, 2021 | Foster Michael Curtis | Chief Legal Officer | Form 4 sale | 50,843 | $856k | 4.5% | Plan not stated | SEC |
| Apr 6, 2021 | Freeman Robert Thomas | Chief Financial Officer | Form 4 sale | 38,919 | $655k | 4.2% | Plan not stated | SEC |
| Apr 6, 2021 | Maroney Dawn Christine | President, Markets | Form 4 sale | 75,222 | $1.3M | 4.4% | Plan not stated | SEC |
| Apr 6, 2021 | General Atlantic LLC | Director, 10% owner | Form 4 sale | 2.2M | $36.7M | 2.8% | Plan not stated | SEC |
| Apr 6, 2021 | Margolis Jeffrey H | Director | Form 4 sale | 10,121 | $170k | 2.1% | Plan not stated | SEC |
| Apr 6, 2021 | McClellan Mark B. | Director | Form 4 sale | 12,103 | $204k | 4.1% | Plan not stated | SEC |
| Apr 6, 2021 | General Atlantic Partners 95, L.P. | Director, 10% owner | Form 4 sale | 2.2M | $36.7M | 2.8% | Plan not stated | SEC |
| Mar 30, 2021 | Warburg Pincus LLC | Director, 10% owner | Form 4 sale | 1.3M | $21.1M | 4.7% | Plan not stated | SEC |
| Mar 30, 2021 | General Atlantic (ALN HLTH), L.P. | Director, 10% owner | Form 4 sale | 3.9M | $64.8M | 4.7% | Plan not stated | SEC |
| Mar 30, 2021 | WP XII Partners, L.P. | Director, 10% owner | Form 4 sale | 1.3M | $21.1M | 4.7% | Plan not stated | SEC |
| Mar 30, 2021 | Gapco Gmbh & Co Kg | Director, 10% owner | Form 4 sale | 3.9M | $64.8M | 4.7% | Plan not stated | SEC |